Hook / Thesis
RTX Corporation is sitting on a rare combination for a major aerospace-defense contractor: a record backlog (reported at $289 billion) and improving demand visibility across commercial and defense platforms. The market has already priced some of that future revenue into the share price, but it has not fully assumed a material improvement in margin profile or faster-than-expected RPO conversion. If Pratt & Whitney and Raytheon Missiles & Defense (RMD) can deliver modest margin expansion and higher free cash flow conversion, the company’s current multiples look vulnerable to an upward re-rate.
In short: this is a long trade that bets on margin recovery unlocking incremental free cash flow from an expanding backlog. The entry is tactical around the current price, the stop protects against program execution or macro setbacks, and the target reflects a re-rating toward historical highs plus a conservative premium for backlog optionality.
Business snapshot - why the market should care
RTX operates across four businesses: Collins Aerospace (avionics, interiors, mechanical systems), Pratt & Whitney (aircraft engines and auxiliary power units), Raytheon Intelligence and Space (sensors, software, cyber), and Raytheon Missiles & Defense (end-to-end missile systems). That breadth gives RTX exposure to commercial aerospace recovery (Pratt & Collins) and an ongoing defense replenishment cycle (RIS and RMD).
The headline number investors should focus on is the $289 billion backlog, which management and industry reports suggest could grow toward roughly $460.5 billion by 2028 as replenishment and international demand accelerate. Not all backlog is equal - about 45% of RPO is reportedly tied to long-term maintenance and sustainment, which tends to be lower execution risk and steadier margin conversion. Importantly, recent awards include a reported $22.9 billion Tomahawk missile order and multiple framework agreements with the Department of Defense that could expand volumes materially.
What the numbers say
RTX’s market snapshot shows a market capitalization roughly at $255.3 billion and an enterprise value near $284.3 billion. The company is generating sizeable free cash flow - reported free cash flow is about $11.41 billion - but valuation multiples are not cheap: P/E sits in the low-30s (around 33x), EV/EBITDA is roughly 20x, and price-to-free-cash-flow near 22x. Return on equity is a healthy ~11.7% and debt-to-equity sits at a moderate 0.56x, leaving balance sheet flexibility for buybacks or bolt-on M&A.
Technically, the stock is in an oversold condition: the RSI is about 29, and the share price at roughly $189.56 trades below its 10/20/50-day moving averages. That combination - strong fundamental backlog plus short-term technical fatigue - creates a logical entry window for a measured long position aimed at a re-rating driven by margin improvement rather than simply optical revenue growth.
Valuation framing
RTX is not a deep-value play; the market already gives the company credit for its backlog and steady profitability. At a market cap of ~$255.3 billion and EV/EBITDA near 20x, the stock looks priced for mid-single-digit to low-teens earnings growth plus stable margins. The upside in this trade comes from modest margin expansion (a couple hundred basis points) and a higher FCF conversion rate from backlog conversion and sustainment revenues. That combination could compress the P/FCF multiple from the current ~22x to the high-teens, which supports a share price closer to the $220-$240 range, assuming steady top-line execution.
Without a detailed peer table in this note, think of valuation qualitatively: RTX sits between low-growth defense peers trading on mid-teens multiples and higher-growth aerospace/engine peers that occasionally trade at premium multiples when technical performance and aftermarket margins improve. Margin upside would shift RTX’s profile toward the premium end of that spectrum.
Catalysts (events that could re-rate the stock)
- 09/22/2026 - Backlog visibility comments and large Tomahawk award: continued constructive commentary or follow-on awards would reinforce the $289B backlog growth thesis and could provide tangible revenue flow over the next 24 months.
- Better-than-expected quarterly margins at Pratt & Whitney or RMD - even a 200-300 bps improvement would materially lift operating income and FCF.
- Stronger aftermarket/maintenance revenues where ~45% of RPO sits - evidence of higher-margin, lower-risk conversion would support valuation expansion.
- Positive free cash flow beats and a commitment to shareholder returns (buybacks or a higher dividend) that signal management confidence in durable cash generation.
Trade plan (actionable)
| Plan | Detail |
|---|---|
| Trade Direction | Long |
| Entry Price | $189.56 |
| Stop Loss | $170.00 |
| Target Price | $230.00 |
| Horizon | Long term (180 trading days) - allow time for margin improvement to materialize across business units and for backlog awards to convert into visible revenue and FCF. |
| Risk Level | Medium |
Rationale: The $189.56 entry captures the stock while technicals are weak but fundamental upside is plausible. The $170 stop limits size to roughly -10% from entry; the $230 target assumes multiple expansion and partial realization of backlog optionality. Given program timelines and contract conversion cadence, expect this trade to take multiple quarters to work, hence the 180-trading-day horizon.
Risks and counterarguments
- Execution risk on major programs - Aerospace programs are complex. Delays, cost overruns, or supply-chain disruptions (particularly at Pratt & Whitney or Collins) could compress margins and push out cash flow realization.
- Defense budget and award timing - While demand is structurally strong, actual award timing for framework agreements and large contracts can shift with budget cycles or reprioritization, delaying backlog conversion into revenue.
- Valuation vulnerability - RTX trades at roughly 33x earnings and ~20x EV/EBITDA. If macro conditions weaken and multiples compress, the stock could fall even with stable fundamentals.
- Commercial aerospace cyclicality - A slowdown in global commercial air travel or airline capex could hit Pratt & Whitney and Collins top-line and delay margin recovery.
- Integration and margin mix - The company’s segment mix matters: if a larger share of revenue comes from low-margin defense sustainment, overall margin expansion could be muted despite higher revenue.
Counterargument: A reasonable bear case is that the market has already baked in the backlog growth and the remaining upside requires sustained margin expansion across several businesses simultaneously. If only top-line growth occurs without margin improvement, RTX’s current multiples are unlikely to expand materially and the stock could remain range-bound.
Why I still prefer the long
I favor the long because the biggest lever here is margin recovery and FCF conversion, not simply revenue growth. RTX has a sizeable FCF base (~$11.4B) and a moderate balance sheet (debt-to-equity ~0.56x). Those two facts mean that incremental margin expansion disproportionately flows to free cash flow and shareholder returns, which tends to drive a multiple re-rating. Additionally, the defense replenishment cycle (and recent large awards) gives revenue visibility that is less cyclical than pure commercial OEM exposure.
What would change my mind
I would abandon this trade if any of the following occur: (1) a public miss on margins at a major segment like Pratt & Whitney or RMD that cannot be explained by one-offs; (2) a major program write-down or multi-quarter production delay tied to supply-chain failures; (3) signs that DoD framework agreements are being scaled back or delayed materially; or (4) a macro shock that rerates the whole sector such that multiples compress several turns regardless of company performance.
Conclusion
RTX is a pragmatic buy here for disciplined traders who believe the company can convert a growing backlog into higher-margin, higher-quality cash flow. The stock is not cheap on headline multiples, but margin expansion plus improved FCF conversion could justify a meaningful upside. The trade plan gives a sensible entry at $189.56, a protective $170 stop and a $230 target over a 180-trading-day horizon. Manage size to reflect the execution risks above and treat this as a catalyst-driven, event-monitored position rather than a blind momentum bet.
Key Points
- Record $289B backlog with potential to expand to ~$460.5B by 2028; important awards (Tomahawk order, DoD frameworks) support revenue visibility.
- Market cap near $255.3B; EV ~$284.3B; free cash flow roughly $11.41B; P/E ~33x and EV/EBITDA ~20x - valuation requires margin improvement to re-rate.
- Technicals show oversold conditions (RSI ~29), creating a disciplined entry opportunity.
- Trade plan: Long at $189.56, stop $170.00, target $230.00, horizon long term (180 trading days), risk medium.